Document is current
Any future updates will be listed below
-
Authors
Mombo-Ngoma, Ghyslain
Meneguim, Augusto
Zoleko Manego, Rella
Ntoumi, Francine
Egger-Adam, Diane
Shin, Jangsik
Adegnika, Ayola Akim
Arbe-Barnes, Sarah
Borghini-Fuhrer, Isabelle
Duparc, Stephan
Kremsner, Peter G.
Ramharter, Michael
Cook, Jackie
Groger, Mirjam
-
Funding
Funding for this research was provided by:
Bernhard-Nocht-Institut für Tropenmedizin
- License Information
-
More Information
Article History
Received: 30 June 2026
Accepted: 10 September 2026
First Online: 17 September 2026
Declarations
Ethics approval and consent to participate: All patients, or their parents/guardians, provided written informed consent, and children able to understand the study gave written assent. The original study was conducted in compliance with the Declaration of Helsinki and Good Clinical Practice according to the ICH-CPMP/ICH/135/95. Ethics approval was obtained from the Comité National d’Ethique et de la Recherche Scientifique (number 041/2018/PR/SG/CNE) and from the Research Ethics Committee of the London School of Hygiene and Tropical Medicine (number 31726), for the secondary data analysis, using an anonymized subset of the data.
Consent for publication: Not applicable.
Competing interests: The authors of this manuscript have the following competing interests: JS is an employee of Shin Poong Pharmaceuticals Co. Ltd. IB-F and SD are employees of Medicines for Malaria Venture. SA-B is employee of Artemida Pharma which received funding from Shin-Poong associated with this study. All other authors have no conflicts of interest to disclose.
